Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
Contributeurs/tricesVellas, Bruno; Coley, Nicola; Ousset, Pierre-Jean; Berrut, Gilles; Dartigues, Jean-François; Dubois, Bruno; Grandjean, Hélène; Pasquier, Florence; Piette, François; Robert, Philippe; Touchon, Jacques; Garnier, Philippe; Mathiex-Fortunet, Hélène; Andrieu, Sandrine; GuidAge study group
Collaborateurs/tricesSaj, Arnaud
Publié dansLancet neurology, vol. 11, no. 10, p. 851-859
Date de publication2012
Résumé
Mots-clés
- Aged
- Aged, 80 and over
- Alzheimer Disease/diagnosis/genetics/prevention & control
- Double-Blind Method
- Female
- Humans
- Male
- Memory Disorders/diagnosis/drug therapy
- Phytotherapy
- Plant Extracts/administration & dosage/adverse effects
- Time Factors
- Treatment Outcome
Groupe de recherche
Citation (format ISO)
VELLAS, Bruno et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. In: Lancet neurology, 2012, vol. 11, n° 10, p. 851–859. doi: 10.1016/S1474-4422(12)70206-5
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:38409
- DOI : 10.1016/S1474-4422(12)70206-5
- PMID : 22959217
ISSN du journal1474-4422
